ANP32A peptide

ANP32A peptide

Proteins & Peptides

Article No

GTX26241

Size

50µg

Application

Inhibition, Neutralization

Article No

GTX26241

Size

50µg

Application

Inhibition, Neutralization

Specifications

Application Inhibition, Neutralization
Article No GTX26241
Country Availability SE, FI, DK, NO, IS, EE, LV, LT
Concentration 0.20 mg/ml
Conjugation Unconjugated
Description ANP32A peptide
Supplier GeneTex
Entrez Gene ID 8125
Gene Symbol ANP32A
Notes Apoptosis is related to many diseases and development. Caspase-9 plays a central role in cell death induced by a variety of apoptosis activators. Cytochrome c, after release from mitochondria, binds to Apaf-1, which forms an apoptosome that in turn binds to and activates procaspase-9. Activated caspase-9 cleaves and activates the effector caspases (caspase-3, -6 and -7), which are responsible for the proteolytic cleavage of many key proteins in apoptosis. The tumor suppressor putative HLA-DR-associated proteins (PHAPs) were recently identified as important regulators of mitochondrion apoptosis. PHAP appears to facilitate apoptosome-mediated caspase-9 activation and to stimulate the mitochondrial apoptotic pathway. PHAP was also shown to oppose both Ras- and Myc-mediated cell transformation.
Product Type Proteins & Peptides
Protocol The peptide is used for blocking the activity of PHAP I antibody (cat. no GTX25992). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 30 min at 37C.
Size 50µg
Storage -20°C
Product Page Updated 2024-01-03T10:31:47.950Z

Documentation

Shipping info
The delivery time for this item is approximately 7-10 business days. Read more